A038070 Stock Overview
Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 1/6 |
Seoulin Bioscience Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩8,760.00 |
52 Week High | ₩12,833.05 |
52 Week Low | ₩7,207.60 |
Beta | 0.79 |
1 Month Change | -5.81% |
3 Month Change | -7.20% |
1 Year Change | -27.25% |
3 Year Change | -34.13% |
5 Year Change | 7.11% |
Change since IPO | 4.17% |
Recent News & Updates
Recent updates
Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Is An Attractive Dividend Stock - Here's Why
May 03Should Weakness in Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Mar 13Introducing Seoulin BioscienceLtd (KOSDAQ:038070), A Stock That Climbed 54% In The Last Year
Feb 15Is Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) A Great Dividend Stock?
Jan 20Three Days Left Until Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070) Trades Ex-Dividend
Dec 25Is Seoulin Bioscience Co.,Ltd.'s (KOSDAQ:038070) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Dec 06Shareholder Returns
A038070 | KR Biotechs | KR Market | |
---|---|---|---|
7D | 0.6% | 3.5% | 2.1% |
1Y | -27.3% | 7.0% | 6.6% |
Return vs Industry: A038070 underperformed the KR Biotechs industry which returned 7% over the past year.
Return vs Market: A038070 underperformed the KR Market which returned 6.6% over the past year.
Price Volatility
A038070 volatility | |
---|---|
A038070 Average Weekly Movement | 5.5% |
Biotechs Industry Average Movement | 8.0% |
Market Average Movement | 5.1% |
10% most volatile stocks in KR Market | 11.8% |
10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A038070 has not had significant price volatility in the past 3 months.
Volatility Over Time: A038070's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1984 | 103 | Eul-Moon Hwang | www.seoulin.co.kr |
Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd.
Seoulin Bioscience Co.,Ltd. Fundamentals Summary
A038070 fundamental statistics | |
---|---|
Market cap | ₩74.93b |
Earnings (TTM) | -₩117.55m |
Revenue (TTM) | ₩89.57b |
0.8x
P/S Ratio-637.4x
P/E RatioIs A038070 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A038070 income statement (TTM) | |
---|---|
Revenue | ₩89.57b |
Cost of Revenue | ₩69.70b |
Gross Profit | ₩19.87b |
Other Expenses | ₩19.99b |
Earnings | -₩117.55m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -13.74 |
Gross Margin | 22.18% |
Net Profit Margin | -0.13% |
Debt/Equity Ratio | 7.3% |
How did A038070 perform over the long term?
See historical performance and comparison